Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-12 · accession 0001106578-25-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-13 | 2025-11-12+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $594.48 | -8,000 | 3,630 | -69% | -$4.76M |
| DMT | 2025-11-13 | 2025-11-12+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-13 | 2025-11-12+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -8,000 | 98.0K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | S | D | 761 | $458.48 | 3,369 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-13 | S | D | 1,299 | $461.17 | 2,070 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $460.88 to $461.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-11-13 | S | D | 1,290 | $1,290.00 | 780 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $466.045 to $466.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-11-13 | S | D | 650 | $467.39 | 130 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $167.195 to $467.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2025-11-12 | S | D | 520 | $457.54 | 3,110 | D | — | — | |
| 6 | Common | Common Stock | 2025-11-12 | S | D | 980 | $458.71 | 2,130 | D | — | — | |
| 7 | Common | Common Stock | 2025-11-12 | S | D | 1,000 | $463.24 | 130 | D | — | — | |
| 8 | Common | Common Stock | 2025-11-13 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 9 | Common | Common Stock | 2025-11-12 | S | D | 800 | $461.14 | 1,330 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $460.96 to $461.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2025-11-12 | S | D | 200 | $462.02 | 1,130 | D | — | — | |
| 11 | Common | Common Stock | 2025-11-12 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 12 | Common | Common Stock | 2025-11-12 | S | D | 500 | $455.97 | 3,630 | D | — | — | |
| 13 | Derivative | Stock Option | 2025-11-12 | M | D | 4,000 | $0.00 | 102,000 | D | $120.26 · 2016-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 14 | Derivative | Stock Option | 2025-11-13 | M | D | 4,000 | $0.00 | 98,000 | D | $120.26 · 2016-03-15 to 2026-03-15 | 4,000 Common Stock |